Anzeige
Mehr »
Login
Montag, 31.03.2025 Börsentäglich über 12.000 News von 696 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0MKPR | ISIN: FR0010425595 | Ticker-Symbol: ZVA
Tradegate
26.03.25
20:44 Uhr
1,268 Euro
+0,044
+3,59 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
CELLECTIS SA Chart 1 Jahr
5-Tage-Chart
CELLECTIS SA 5-Tage-Chart
RealtimeGeldBriefZeit
1,2301,23810:43
1,2141,22809:52

Aktuelle News zur CELLECTIS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
14.03.Cellectis Non-GAAP EPS of -$0.16 beats by $0.05, revenue of $33.22M beats by $23.63M10
13.03.Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2024 and Provides a Business Update149? UCART22 Phase 1 dataset and late-stage development strategy expected in the third quarter of 2025; Orphan Drug Designation (ODD) and Rare Pediatric Disease Designation (RPDD) granted by FDA and...
► Artikel lesen
07.03.Cellectis to Report Fourth Quarter and Full Year 2024 Financial Results on March 13, 20251
07.03.Cellectis S.A. - 6-K, Report of foreign issuer1
06.03.Cellectis Inc.: Monthly information on share capital and company voting rights3
24.02.Cellectis S.A. - 6-K, Report of foreign issuer1
CELLECTIS Aktie jetzt für 0€ handeln
24.02.Cellectis Presents 'Smart CAR T' Strategy to Enhance Efficacy Against Solid Tumors at AACR-IO 20253
04.02.Cellectis Inc.: Monthly information on share capital and company voting rights7
15.01.Cellectis S.A announces potential resale of up to 44M shares15
15.01.Cellectis S.A. - S-8, Securities to be offered to employees in employee benefit plans10
08.01.Cellectis Inc.: Monthly information on share capital and company voting rights5
10.12.24Cellectis announces the drawdown of the third tranche of €5 million under the credit facility agreement entered with the European Investment Bank (EIB)18
10.12.24Cellectis S.A. - 6-K, Report of foreign issuer-
04.12.24Cellectis Inc.: Monthly information on share capital and company voting rights7
06.11.24Cellectis Inc.: Monthly information on share capital and company voting rights4
06.11.24Earnings call: Cellectis reports robust cash reserves, new R&D initiatives26
05.11.24Cellectis Presents Multiple Strategies to Enhance CAR T-cell Efficacy in Solid Tumors at the SITC Annual Meeting1
05.11.24Baird maintains $10 target on Cellectis amid strong AZN partnership8
05.11.24Baird hält am Kursziel von 10 US-Dollar für Cellectis fest angesichts starker AZN-Partnerschaft25
05.11.24Cellectis drops one of its 3 clinical-stage CAR-Ts3
Seite:  Weiter >>
38 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1